WA-MARY-KAY
2.6.2022 22:55:07 CEST | Business Wire | Press release
Calling all models—your virtual runway awaits! Step & Repeat, the first ever style and fashion competition launched on TikTok, returns for season two on June 7. Last year, Glamhive and Mary Kay Global Design Studio unveiled the fashion reality contest that reached millions of users worldwide. Now, the four-week style challenge is back and promises to be the fashion extravaganza we’ve all been waiting for.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220602005868/en/
Celebrity Stylist Zadrian Smith (clients include: Ariana DeBose, Naama Preis, Naomi Scott) hosts Step & Repeat with three judges and industry favorites: celebrity stylist Tara Swennen (clients include: Kristen Stewart, Matthew McConaughey), celebrity stylist Nicole Chavez (clients include: Kristen Bell, Jessica Simpson), and celebrity hairstylist Larry Sims (clients include: Victoria Beckham, Queen Latifah).
Each week, host Zadrian Smith will announce a theme-based challenge for TikTok users to showcase their creativity through wardrobe, makeup, and hair. The show’s celebrity judges will duet the best looks from around the world and cast their votes for winners in each category. Participants are asked to incorporate the show’s custom sound, “Step & Repeat,” and hashtags, #stepandrepeat, #glamhive, and #marykay to enter their video into the competition. For each challenge there will be three winners, hand-picked by the judges, who will receive a cash prize plus an hour one-on-one meeting with an industry mentor.
At the end of the four weeks, Step & Repeat will announce one overall winner for each category, crowning them the very best in wardrobe, makeup, and hair based on entries from all over the world. TikTok is the place for anyone with talent and a creative voice to share their gift on a global scale. Step & Repeat is the platform that gives you the opportunity to be seen and celebrated.
Zadrian Smith, Celebrity Stylist (Host)
“As my career has progressed as a Global Fashion Director and Journalist, I’ve wanted to prioritize working to create a more equitable fashion industry. It’s not always easy or comfortable work, but any opportunity that I can provide to help other people interested in the industry with a step up - that’s a conversation that I want to be a part of.”
Tara Swennen, Celebrity Stylist (Judge)
“There are so many people with incredible creative talent and Step & Repeat gives them a place to shine. I'm very excited to see the looks that people from all over the world will be debuting on our social media runway!”
Nicole Chavez, Celebrity Stylist (Judge)
“Season One of ‘Step & Repeat’ absolutely inspired me. I was excited every week to see what the contestants created and blown away by the range of talent. I can't wait to see the results of our challenges in Season Two!”
Larry Sims, Celebrity Hairstylist (Judge)
“It takes courage, confidence, & creativity to show the world why you're an amazing artist. I’m excited to see the contestants bring it!”
Stephanie Sprangers, Founder and CEO of Glamhive
“Our vision for ‘Step & Repeat’ was to create a fast-paced style competition that encompassed creativity, inclusivity, connections, and recognition, and Season One delivered in spades. Now, for the second time, the industry's best are coming together to welcome and encourage style talent from around the world. We're so excited to see what happens in Season Two.”
Step & Repeat Mentors:
- Claire Sulmers, CEO & Founder of Fashion Bomb Daily
- Adam Drawas, Owner, Walker Drawas PR
- Quentin Thrash, Bespoke Designer & Celebrity Barber
- Brian Underwood, Fashion Director, Women’s Health
- Mandi Line, Costume Designer (The Bold Type, Pretty Little Liars, Shameless)
- Pandora Amoratis, Style Director, US Daily Mail
- Sheridan Ward, Celebrity Hairstylist
- Shatora Adrell, Fashion Designer and Stylist
- Carrie Colbert, Founding & General Partner, Curate Capital
- Quinn Murphy, Celebrity Makeup Artist
- Alexis Bennett, Editor, Vogue
- Gilda Koral Flora, Founder, Koral Communications
- Christian Wood, Celebrity Hairstylist
For more information, visit https://www.glamhive.com/tiktok
About Glamhive: Glamhive was founded by entrepreneur Stephanie Sprangers in 2017 with the vision to democratize personal styling and the premise that the confidence that comes with glamour should not be exclusive to the rich and famous. The online styling experience offers anyone with a WiFi connection access to stylists who will provide them with the support they need to be the best version of themselves. For stylists, it is a seamless end-to-end platform to help them grow their network and their business, 100% virtually.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com , find us on Facebook , Instagram , and LinkedIn , or follow us on Twitter .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005868/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom